Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Zynerba Pharmaceuticals Inc | ZYNE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 11.90 | 0.00 | 0.00 | 0.00 | 11.90 | 04:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 11.95 | 12.50 | 0.55 | 4.40% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.00 | USD |
Zynerba Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 276.06M | 23.20M | $ -39.91M | -2.67 | - | 21.06M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Zynerba Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZYNE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 10.93 | 12.51 | 10.6 | 11.4904 | 703k | 0.97 | 8.87% |
| 1 Month | 11.41 | 12.51 | 9.05 | 10.9248 | 905k | 0.49 | 4.29% |
| 3 Months | 13 | 15.6973 | 9.05 | 12.5434 | 2M | -1.1 | -8.46% |
| 6 Months | 5.26 | 16.47 | 4.4601 | 10.8458 | 2M | 6.64 | 126.24% |
| 1 Year | 6.31 | 16.47 | 2.75 | 9.6689 | 1M | 5.59 | 88.59% |
| 3 Years | 9.89 | 25.95 | 2.75 | 10.8613 | 739k | 2.01 | 20.32% |
| 5 Years | 18 | 43 | 2.75 | 11.0314 | 594k | -6.1 | -33.89% |
Zynerba Pharmaceuticals Description
| Zynerba Pharmaceuticals Inc together with its subsidiary is a pharmaceutical company which is focused on developing and commercializing proprietary next generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates are ZYN001 and ZYN002. The company has initiated a clinical trial for both the product candidates. |
